Germany's Evonik completes long-awaited stock market listing

25 April 2013 10:39  [Source: ICIS news]

LONDON (ICIS)--After several false starts dating back to 2008, German chemicals giant Evonik went public on Thursday, with shares up in early day trading.

Some 14.5% of the company has been placed in free float in the form of 466 million shares, with 12.2% of that total sold in private placements in February and March this year.

Evonik said on Thursday that the company had sold an additional 2.3% stake to domestic and institutional investors on 24 April, ahead of the listing, for a price of €32.20 ($41.82) per share. Shares were trading at €32.89 apiece in Frankfurt as of 09:37 GMT, from early-day highs of €33.20. The company described the number of investors as in the "low three-digit[s]".

Following the listing, the RAG Foundation – which previously held 74.99% of the company – has reduced its stake to 68.9%, while former 25.01% stakeholder – private equity firm CVC Capital Partners – has reduced its stake to 18.9%.

Singapore-based sovereign wealth fund Temasek now holds 4.6% of the company through a wholly-owned subsidiary, according to Evonik’s initial public offering (IPO) prospectus.

The RAG Foundation had originally planned to list the company in 2008, but scrapped plans as a result of the global economic crisis, opting instead to sell a 25.01% stake to CVC.

Another attempted listing was cancelled in 2012 due to the weak European economy.

($1 = €0.77)

By: Tom Brown
+44 208 652 3214

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly

Get access to breaking chemical news as it happens.
ICIS Global Petrochemical Index (IPEX)
ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index